482 Followers on Owler

BerGenBio

is a Norway-based clinical-stage biopharmaceutical company that researches and develops AXL therapeutics for the treatment of cancer and COVID -19... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

BerGenBio

is a Norway-based clinical-stage biopharmaceutical company that researches and develops AXL therapeutics for the treatment of cancer and COVID -19... Read more
BerGenBio CEO: Olav Hellebø

CEO

Olav Hellebø

CEO Approval Rating

- -/100

2007

Bergen
Other

PublicFRA7BG

Pharmaceuticals & Biotechnology
Biotechnology

Annual Revenue
$ < 1M
Employees
15
Funding
$143.3M
Investments
1

News

Leadership Change
Nov 21, 2024
PR Newswire
Olav Hellebø joined BerGenBio as CEO

BerGenBio Competitors

1Genmab
2Xellia
3PharmaLex
4Veru
5AstraZeneca
6CTI BioPharma
7Ipsen
8Cue Biopharma
Unlock 5 + competitors

Trending Companies